Latest Antimalarial medication Stories

Chinese malaria drugs giant, Guilin, launches effort in Africa to enable patients and consumers detect fake malaria drugs using mobile phone technology, goldkeys. Shanghai, China (PRWEB) May 15, 2013 Guilin Pharmaceuticals, the World’s first producer of artesunate prequalified by the World Health Organisation as meeting the global body’s stringent standards for safety, quality and efficacy, has chalked another first. The company, which manages the world’s largest vertically...

SEATTLE, May 7, 2013 /PRNewswire/ -- Plandai Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, today announced the formation of Phyto Pharmacare, Inc., a Delaware corporation, which will oversee all aspects of developing and marketing Phytofare(TM) extracts for pharmaceutical and drug applications. Plandai Chief Executive Officer Roger Duffield commented, "As a...

-- Power of One donation campaign harnesses the latest web and mobile technology to rally the global public to fight malaria BASEL, Switzerland, April 25, 2013 /PRNewswire/ -- Novartis and Malaria No More, a leading global charity determined to end malaria deaths, announced today that they are joining forces on the Power of One campaign to help close the treatment gap and accelerate progress in the fight against malaria. Over the next three years, Novartis will support the...

Novartis, Alere, Time Warner, Twitter, and more sign on to help close malaria testing and treatment gaps in Africa NEW YORK, April 25, 2013 /PRNewswire-USNewswire/ -- Malaria No More announced today, World Malaria Day, that some of the world's most innovative companies have signed on for the Power of One campaign, which will use the latest social, mobile, and e-commerce technologies to rally the global public to close malaria testing and treatment gaps in Africa. A child dies every...

University of California - Berkeley Twelve years after a breakthrough discovery in his University of California, Berkeley, laboratory, professor of chemical engineering Jay Keasling is seeing his dream come true. On April 11, the pharmaceutical company Sanofi will launch the large-scale production of a partially synthetic version of artemisinin, a chemical critical to making today's front-line antimalaria drug, based on Keasling's discovery. The drug is the first triumph of the...

Griffith University researchers map out new approach An international study, involving researchers from Griffith University's Eskitis Institute, has discovered a molecule which could form the basis of powerful new anti-malaria drugs. Professor Vicky Avery from Griffith University's Eskitis Institute is co-author of the paper "Quinolone-3-Diarylethers: a new class of drugs for a new era of malaria eradication" which has been published in the journal Science Translational Medicine....

Drug may be major advance as malaria has developed resistance to existing treatments Scientists at Oregon Health & Science University and the Portland VA Medical Center have developed a drug that may represent one of the world's best hopes for treating and preventing malaria — a disease that kills more than one million people each year. The scientists have described the drug, and its effectiveness against mice infected with malaria, in the March 20 issue of Science Translational...

VANCOUVER, British Columbia, March 8, 2013 /PRNewswire/ -- Abattis Bioceuticals Corp. ("Abattis" or the "Company") (CNSX: FLU) (OTC: ATTBF), is pleased to announce its participation in a research project led by Pamela Weathers, Professor of Biology and Biotechnology at Worcester Polytechnic Institute (WPI) in Worcester, Mass. that is investigating a whole plant therapeutic for treating malaria and other diseases, one that may also reduce drug resistance. Mr. Mike Withrow, Chief...

Early diagnosis and treatment with antimalarial drugs (ACTs—artemisinin based combination treatments) has been linked to a reduction in malaria in the migrant population living on the Thai-Myanmar border, despite evidence of increasing resistance to ACTs in this location, according to a study by international researchers published in this week's PLOS Medicine. These findings are important as this study suggests that alternative treatments are urgently needed to replace the failing first...

New research has revealed that immature malaria parasites are more resistant to treatment with key antimalarial drugs than older parasites, a finding that could lead to more effective treatments for a disease that kills one person every minute and is developing resistance to drugs at an alarming rate. University of Melbourne researchers have shown for the first time that malaria parasites (Plasmodium falciparum)in the early stages of development are more than 100 times less sensitive to...